ESMO - Eur. Oncology on X: "#ESMO18 is slowly coming to a close. The science, the education, the peer connections; everything came together for an exceptional congress. Many thanks to all of
ESMO Asia 2018 Congress | Singapore Oncology Conference
PosterSessionOnline
GUSTAVE ROUSSY AT ESMO 2018
Industry Sponsored Satellite Symposia | ESMO
ESMO Asia 2018 YO Poster Display Instructions
PosterSessionOnline
Table of Contents page: Annals of Oncology
Posters and Oral presentations – Circio
Information for Presenters | ESMO Immuno-Oncology Congress 2023
ESDO: GI Slide Decks
ESMO 2018 Congress: ICHOM - All.Can - All.Can
Poster presented at ESMO 2018 Congress: 430P - Phase I study: Safety and tolerability of Varlitinib (VAR) in combination with Oxaliplatin and Capecitabine (COX) or Oxaliplatin and 5-FU (FOL) in advanced solid
LUCE STAND AT ESMO 2018 - Lung Cancer Europe
PosterSessionOnline
Table of Contents page: Annals of Oncology
Posters and Oral presentations – Circio
PosterSessionOnline
Poster presented at ESMO 2018 Congress: 1043TiP - A phase IIA dose optimization study of ASLAN003 in acute myeloid leukemia (AML) - ASLAN Pharmaceuticals
Biocytogen at the at the European Society for Medical Oncology (ESMO) 2018 annual meeting - Biocytogen
Abstracts | ESMO Congress 2022
Webcasts & Presentations | ESMO 2018 Congress
ESMO 2018 Poster Display Instructions
ESMO Immuno Oncology 2018 Poster Discussion Presenters
ACT Genomics SG - ACT Genomics is proud to be selected for abstract poster presentation in ESMO 2018 Congress which starting from today till 23 October at Munich, Germany. In one of
